These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3160638)

  • 1. Plasminogen activator activity in human endometrial carcinoma.
    Whitney CW; Satyaswaroop PG; Mortel R
    Gynecol Oncol; 1985 Sep; 22(1):97-104. PubMed ID: 3160638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
    Feng YJ; Zhang XY
    Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
    Thurzó L; Sas M; Falkay G
    Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasminogen activator activity and steroid receptors in human breast cancer.
    Thorsen T
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):129-32. PubMed ID: 7201390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
    Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM
    Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.
    Quinn MA; Cauchi M; Fortune D
    Gynecol Oncol; 1985 Jul; 21(3):314-9. PubMed ID: 3159630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.
    Carlson JA; Allegra JC; Day TG; Wittliff JL
    Am J Obstet Gynecol; 1984 May; 149(2):149-53. PubMed ID: 6232850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
    Ehrlich CE; Young PC; Cleary RE
    Am J Obstet Gynecol; 1981 Nov; 141(5):539-46. PubMed ID: 6457531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance.
    Kleine W; Maier T; Geyer H; Pfleiderer A
    Gynecol Oncol; 1990 Jul; 38(1):59-65. PubMed ID: 2141316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine aspects of human uterine sarcoma: a preliminary study.
    Tseng L; Tseng JK; Mann WJ; Chumas JC; Stone ML; Mazella J; Sun B; Amalfitano TG; Wallach RC
    Am J Obstet Gynecol; 1986 Jul; 155(1):95-101. PubMed ID: 2942037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of antitumoral activity of medroxyprogesterone acetate for endometrial cancer.
    Fujimoto J; Fujita H; Hosoda S; Okada H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1836-40. PubMed ID: 2531782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content.
    Metzger DA; Lessey BA; Soper JT; McCarty KS; Haney AF
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):946-50. PubMed ID: 1833687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator activity in human breast cancer cytosols.
    Ng R; Sutherland DJ; Kellen JA
    Tumour Biol; 1984; 5(3-4):179-87. PubMed ID: 6390661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
    Thurzó L
    Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptors in human uterine adenocarcinoma: correlation with tissue differentiation, vaginal karyopycnotic index, and effect of progestogen or anti-estrogen treatment.
    Billiet G; De Hertogh R; Bonte J; Ide P; Vlaemynck G
    Gynecol Oncol; 1982 Aug; 14(1):33-9. PubMed ID: 6212297
    [No Abstract]   [Full Text] [Related]  

  • 17. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
    Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
    Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal receptors in endometrial neoplasias.
    Contreras Ortiz O; Sananes CE
    Eur J Gynaecol Oncol; 1988; 9(5):396-8. PubMed ID: 2975993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Growth regulation of sex steroid hormone in endometrial carcinoma transplanted into nude mice].
    Kato Y; Morisawa T; Kuramoto H
    Hum Cell; 1991 Jun; 4(2):165-70. PubMed ID: 1835653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nude mouse system in the study of tumor biology, treatment strategies and progesterone receptor physiology in human endometrial carcinoma.
    Satyaswaroop PG; Zaino R; Clarke CL; Mortel R
    J Steroid Biochem; 1987; 27(1-3):431-8. PubMed ID: 2961935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.